Theseus Pharmaceuticals Inc
(THRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | THRX | AZN | AMGN | GILD | VRTX |
| Company | Theseus Pharmaceuticals Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 4.06 | 187.50 | 339.47 | 141.05 | 466.79 |
| High | 4.07 | 192.79 | 345.98 | 143.80 | 473.74 |
| Low | 4.06 | 186.18 | 339.41 | 140.01 | 464.01 |
| Latest | 4.06 | 188.41 | 344.68 | 142.89 | 472.01 |
| Change | unch | +95.64 | +2.80 | +0.94 | +2.11 |
| % Change | unch | +103.09% | +0.82% | +0.66% | +0.45% |
| Volume | 3,123,100 | 3,228,700 | 1,899,800 | 6,898,200 | 759,700 |
| 20-Day Average Volume | 578,445 | 9,430,835 | 2,766,525 | 7,869,025 | 1,530,345 |
| Previous Close | 4.06 | 92.77 | 341.88 | 141.95 | 469.90 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 4.04 | 98.24 | 336.36 | 129.18 | 463.27 |
| 20-Day Raw Stochastic | 61.54% | 95.78% | 75.54% | 96.62% | 73.50% |
| 20-Day Relative Strength | 60.97 | 91.25 | 57.80 | 70.20 | 57.07 |
| Weighted Alpha | -14.40 | +68.67 | +21.88 | +52.06 | +6.15 |
| Today's Opinion | 40% Buy | 100% Buy | 100% Buy | 100% Buy | 88% Buy |
| Previous Opinion | 40% Buy | 88% Buy | 100% Buy | 100% Buy | 88% Buy |
| Last Month's Opinion | 8% Buy | 100% Buy | 80% Buy | 64% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.49% since 02/06/24 | +99.95% since 01/26/26 | -1.43% since 01/26/26 | +3.71% since 01/26/26 | -1.01% since 01/26/26 |
| Low | 4.06 on 02/13/24 | 92.46 on 01/30/26 | 338.07 on 01/30/26 | 137.54 on 01/27/26 | 464.01 on 02/02/26 |
| High | 4.11 on 02/07/24 | 192.79 on 02/02/26 | 353.25 on 01/27/26 | 143.80 on 02/02/26 | 485.00 on 01/27/26 |
| 1-Month | |||||
| %Chg | +0.74% since 01/12/24 | +105.76% since 01/02/26 | +5.20% since 01/02/26 | +17.51% since 01/02/26 | +4.40% since 01/02/26 |
| Low | 3.98 on 01/22/24 | 89.04 on 01/21/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 429.00 on 01/20/26 |
| High | 4.11 on 02/07/24 | 192.79 on 02/02/26 | 353.25 on 01/27/26 | 143.80 on 02/02/26 | 487.52 on 01/07/26 |
| 3-Month | |||||
| %Chg | +89.72% since 11/13/23 | +128.65% since 10/31/25 | +15.50% since 10/31/25 | +19.28% since 10/31/25 | +10.91% since 10/31/25 |
| Low | 2.92 on 11/14/23 | 80.48 on 11/04/25 | 292.12 on 11/03/25 | 116.88 on 01/05/26 | 403.16 on 11/04/25 |
| High | 4.20 on 12/27/23 | 192.79 on 02/02/26 | 353.25 on 01/27/26 | 143.80 on 02/02/26 | 487.52 on 01/07/26 |
| 6-Month | |||||
| %Chg | +30.13% since 08/11/23 | +154.78% since 08/01/25 | +16.10% since 08/01/25 | +26.25% since 08/01/25 | +2.14% since 08/01/25 |
| Low | 2.05 on 11/13/23 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 362.50 on 08/11/25 |
| High | 4.20 on 12/27/23 | 192.79 on 02/02/26 | 353.25 on 01/27/26 | 143.80 on 02/02/26 | 487.52 on 01/07/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 179,574 | 287,755,456 | 184,095,904 | 176,114,528 | 119,222,552 |
| Shares Outstanding, K | 44,230 | 3,101,816 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 0 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -50,610,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 0 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -13,500,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 3.98 | 0.34 | 0.45 | 0.33 | 0.31 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.31 on 11/17/23 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 03/14/24 | 02/10/26 | 02/03/26 | 02/10/26 | 02/12/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | 09/08/15 | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.26 | 15.68 | 17.04 | 31.07 |